Denver Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Denver Investment Advisors's GILD Position: Q1 2018 in Review
Denver Investment Advisors reduced its Gilead Sciences (GILD) stake by 5.8% in Q1 2018, selling an estimated $30.4K and leaving 6,170 shares worth $465K. The position accounts for 0.02% of the portfolio, ranked #328.
Denver Investment Advisors first reported a position in GILD in Q2 2013 and has held it in 19 quarters since. The position peaked at $7.68M in Q3 2014. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.
- Denver Investment Advisors held 6,170 shares of Gilead Sciences worth $465K as of Q1 2018.
- Denver Investment Advisors sold 382 Gilead Sciences shares in Q1 2018, an estimated $30.4K.
- Gilead Sciences made up 0.02% of Denver Investment Advisors's portfolio in Q1 2018, its #328 holding.
- Denver Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 19 quarters since.
- Denver Investment Advisors's Gilead Sciences position peaked at $7.68M in Q3 2014.
- 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.
Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.